Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Elanco Animal Health Incorporated (Elanco or the Company) (NYSE: ELAN) securities between January 10, 2020 and May 6, 2020, inclusive (the Class Period). Elanco investors have until July 20, 2020 to file a lead plaintiff motion.
Investors suffering losses on their Elanco investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected].
On May 7, 2020, before the market opened, Elanco announced its first quarter 2020 financial results, reporting revenue of $657.7 million and earnings per share of -$0.12, reflecting a reduction of approximately $60 million in channel inventory. The Companys Chief Executive Officer attributed the disappointing results to distributor performance, among other things, and stated that Elanco planned to tighten [its] approach across many facets of [its] distributor relationships.
On this news, the Companys share price fell $3.05, or over 13%, to close at $19.88 per share on May 7, 2020, on unusually heavy trading volume.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that, after consolidating its distributors from eight to four, the Company increased the amount of inventory, including companion animal products, held by each distributor; (2) that Elancos distributors were not experiencing sufficient demand to sell through the inventory; (3) that, as a result, the Companys revenue was reasonably likely to decline; (4) that, as a result of the foregoing, Elanco would reduce its channel inventory with respect to companion animal products; and (5) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
If you purchased Elanco securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.